Analysis on the Current Development State of Drug Clinical Trial Institutions in Guizhou Province under the Registering System
Objective:To understand the current state of development and issues on drug clinical trial institutions in Guizhou Province after the implementation of drug clinical trial institution registering system in China,and provide suggestions,in order to provide references for supporting the development and construction of drug clinical trial institutions in Guizhou Province.Methods:The data was collected from the national drug clinical trial institution registering management information system platform and the drug clinical trial registration and information publicity platform.A statistical analysis was conducted on the aspects,such as development course,number,and regional distribution of drug clinical trial institutions in Guizhou Province,as well as the registered profession,the principal investigators,clinical trial undertaking and completion status,experimental drug species,and phase I clinical trial.Results and Conclusion:The drug clinical trial institutions in Guizhou Province has developed since the implementation of drug clinical trial institution registering system.Nevertheless,the total number of drug clinical trials is still relatively low.It is suggested that relevant departments should enhance the financial support and policy guidance for drug clinical trial institutions,form professional associations for sharing manufacturing information,collaborate with adjacent provinces to build training facilities,and establish incentive schemes within the institution,in order to foster the development of our province's drug clinical trial institutions.
drug clinical trial institutionsinstitution registering systemdrug regulationdrug research